BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18668204)

  • 1. Cell penetrating peptide inhibitors of nuclear factor-kappa B.
    Orange JS; May MJ
    Cell Mol Life Sci; 2008 Nov; 65(22):3564-91. PubMed ID: 18668204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting proinflammatory NF-kappaB signaling using cell-penetrating NEMO binding domain peptides.
    Madge LA; May MJ
    Methods Mol Biol; 2009; 512():209-32. PubMed ID: 19347279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
    De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
    Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Inflammatory Changes in Human Myometrial Cells by Cell Penetrating Peptide and Small Molecule Inhibitors of NFκB.
    Gurney LRI; Taggart J; Tong WC; Jones AT; Robson SC; Taggart MJ
    Front Immunol; 2018; 9():2966. PubMed ID: 30619324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB as a potential molecular target for cancer therapy.
    Lee CH; Jeon YT; Kim SH; Song YS
    Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling.
    Wang YF; Xu X; Fan X; Zhang C; Wei Q; Wang X; Guo W; Xing W; Yu J; Yan JL; Liang HP
    Mol Ther; 2011 Oct; 19(10):1849-57. PubMed ID: 21556052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IkappaB kinase complex: master regulator of NF-kappaB signaling.
    Solt LA; May MJ
    Immunol Res; 2008; 42(1-3):3-18. PubMed ID: 18626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
    Li X; Massa PE; Hanidu A; Peet GW; Aro P; Savitt A; Mische S; Li J; Marcu KB
    J Biol Chem; 2002 Nov; 277(47):45129-40. PubMed ID: 12221085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic advances in NF-kappaB signaling analysis.
    Kobayashi T; Kageyama R
    Sci Signal; 2009 Jul; 2(81):pe47. PubMed ID: 19638614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
    Freitas RHCN; Fraga CAM
    Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-κB signaling as a strategy in disease therapy.
    Gilmore TD; Garbati MR
    Curr Top Microbiol Immunol; 2011; 349():245-63. PubMed ID: 21113699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
    Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
    J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
    Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
    Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
    Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
    J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway.
    Li G; Fu J; Zhao Y; Ji K; Luan T; Zang B
    Inflammation; 2015 Apr; 38(2):510-9. PubMed ID: 24962643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
    Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
    J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.